Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

被引：0
|
作者：
Ito, Shun [1 ]
Banno, Masahiro [2 ,3 ,4 ]
Okazaki, Yuji [4 ,5 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, 2-17-77,Higashinaniwa Cho, Amagasaki, Hyogo 6608550, Japan
[2] Seichiryo Hosp, Dept Psychiat, 4-16-27,Tsurumai,Showa Ku, Nagoya, Aichi 4660064, Japan
[3] Nagoya Univ, Dept Psychiat,, Grad Sch Med, 65 Tsurumai Cho,Showa Ku, Nagoya, Aichi 4668560, Japan
[4] Sci Res WorkS Peer Support Grp SRWS PSG, Osaka, Japan
[5] Hiroshima City Hiroshima Citizens Hosp, Dept Emergency Med, 7-33 Motomachi,Naka Ku, Hiroshima, Hiroshima 7308518, Japan
来源：
INFECTIOUS DISEASES AND THERAPY | 2023年 / 12卷 / 01期
关键词：
D O I：
10.1007/s40121-022-00728-3
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：299 / 300
页数：2
相关论文
共 50 条
  • [1] Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
    Shun Ito
    Masahiro Banno
    Yuji Okazaki
    Infectious Diseases and Therapy, 2023, 12 : 299 - 300
  • [2] Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia”
    Flavio Mantelli
    Infectious Diseases and Therapy, 2023, 12 : 301 - 302
  • [3] Response to "Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia"
    Mantelli, Flavio
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (01) : 301 - 302
  • [4] A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
    Giovanni Landoni
    Lorenzo Piemonti
    Antonella d’Arminio Monforte
    Paolo Grossi
    Alberto Zangrillo
    Enrico Bucci
    Marcello Allegretti
    Giovanni Goisis
    Elizabeth M. Gavioli
    Neal Patel
    Maria De Pizzol
    Georgea Pasedis
    Flavio Mantelli
    Infectious Diseases and Therapy, 2022, 11 : 1559 - 1574
  • [5] A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
    Landoni, Giovanni
    Piemonti, Lorenzo
    Monforte, Antonella d'Arminio
    Grossi, Paolo
    Zangrillo, Alberto
    Bucci, Enrico
    Allegretti, Marcello
    Goisis, Giovanni
    Gavioli, Elizabeth M.
    Patel, Neal
    De Pizzol, Maria
    Pasedis, Georgea
    Mantelli, Flavio
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (04) : 1559 - 1574
  • [6] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
    Lorenzo Piemonti
    Giovanni Landoni
    Antonio Voza
    Massimo Puoti
    Ivan Gentile
    Nicola Coppola
    Stefano Nava
    Alessia Mattei
    Franco Marinangeli
    Giulia Marchetti
    Paolo Bonfanti
    Claudio Maria Mastroianni
    Matteo Bassetti
    Ernesto Crisafulli
    Paolo Antonio Grossi
    Alberto Zangrillo
    Antonio Desai
    Marco Merli
    Maria Foggia
    Marco Carpano
    Lorenzo Schiavoni
    Antonella D’Arminio Monforte
    Luca Bisi
    Gianluca Russo
    Fabiana Busti
    Cristina Rovelli
    Elisabetta Perrotta
    Giovanni Goisis
    Elizabeth M. Gavioli
    Sophie Toya
    Maria De Pizzol
    Flavio Mantelli
    Marcello Allegretti
    Enrico Maria Minnella
    Infectious Diseases and Therapy, 2023, 12 : 2437 - 2456
  • [7] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
    Piemonti, Lorenzo
    Landoni, Giovanni
    Voza, Antonio
    Puoti, Massimo
    Gentile, Ivan
    Coppola, Nicola
    Nava, Stefano
    Mattei, Alessia
    Marinangeli, Franco
    Marchetti, Giulia
    Bonfanti, Paolo
    Mastroianni, Claudio Maria
    Bassetti, Matteo
    Crisafulli, Ernesto
    Grossi, Paolo Antonio
    Zangrillo, Alberto
    Desai, Antonio
    Merli, Marco
    Foggia, Maria
    Carpano, Marco
    Schiavoni, Lorenzo
    Monforte, Antonella D'Arminio
    Bisi, Luca
    Russo, Gianluca
    Busti, Fabiana
    Rovelli, Cristina
    Perrotta, Elisabetta
    Goisis, Giovanni
    Gavioli, Elizabeth M.
    Toya, Sophie
    De Pizzol, Maria
    Mantelli, Flavio
    Allegretti, Marcello
    Minnella, Enrico Maria
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (10) : 2437 - 2456
  • [8] A phase 3 study to evaluate the efficacy and safety of reparixin in severe COVID-19 pneumonia
    Landoni, G.
    Voza, A.
    Puoti, M.
    Coppola, N.
    Akselrod, H.
    Gavioli, E.
    Minnella, E. M.
    Toya, S.
    Marsiglia, C.
    Sergio, F.
    Allegretti, M.
    Mantelli, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [9] Letter to the editor: Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study
    Bressi, Barbara
    Paltrinieri, Sara
    Fugazzaro, Stefania
    Costi, Stefania
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2021, 43
  • [10] Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial
    Shafiei, Elham
    Mahmoudvand, Golnaz
    Rouzbahani, Arian Karimi
    Nazari, Ali
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2023, 18 (04):
12345